Remove Inventor Remove Licensing Remove Litigation Remove Patent
article thumbnail

Intersection of Intellectual Property Law and Competition Law with respect to Cross Licensing Agreements

IIPRD

This has led to the introduction of intellectual property rights which are a set of exclusionary rights as it excludes the world from enjoying a set of rights arising out an invention or creation, except the inventor or creator. Cross-licensing agreements can both restrain and advance competition.

article thumbnail

mRNA Patent Litigation: The ‘Sport of Kings’

SpicyIP

Moderna recently sued Pfizer alleging patent infringement of three out of eight patents that cover its Covid 19 vaccine (Spikevax). The sheer size of sales and revenue coupled with patent monopolies and the immense potential of the mRNA technology, makes both these entities King-like – rich, supreme and sometimes hypocritical.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Discretionary Remedies Clarified, and Videotron Ltd Successfully Defends Against Much Litigation-Experienced Rovi Guides Inc.

IPilogue

In Rovi Guides Inc v Videotron Ltd , the Federal Court of Canada invalided patents for interactive program guide (“IPG”) technology and clarified a reasonable royalty as the appropriate remedy had the patents been found valid and infringed. Videotron did not renew its license which expired in 2016. Rovi’s conduct.

article thumbnail

District Court Grants Summary Judgment and Invalidates Patent in REGENXBIO v. Sarepta Litigation

LexBlog IP

On January 5, 2024, in litigation between REGENXBIO and Sarepta Therapeutics, Judge Richard Andrews of the U.S. 10,526,617 (the ’617 Patent; licensed to REGENXBIO) is invalid as being directed to ineligible subject matter. A separate, related patent lawsuit filed by REGENXBIO and Penn against Sarepta and Catalent, Inc.

article thumbnail

New IP Monetization Models Will Rely Less on Litigation in 2022

IP Watchdog

In the decade since the America Invents Act (AIA) was enacted, patent licensing challenges have increased for many technology companies and independent inventors. grants for the first half of 2021.

IP 121
article thumbnail

Join the Livestream: How A.I. and Tech are Affecting IP Licensing and Value + “Reaching A New Generation of Inventors”

IP Close Up

Four IP licensing experts will discuss recent changes in the intellectual property licensing landscape, including generative A.I., and how they are affecting innovation. The all-star Continue reading

article thumbnail

Google’s dialogue in the conversation of improving the US Patent System

IPilogue

Google’s contribution to the US patent system. Healthy patent systems can sometimes be described as a way to incentivize creative inventions, encourage building on existing ideas, and avoid frivolous litigation. Google also helped discover the License on Transfer Network. Concern with the US patent system.